Document is current
Any future updates will be listed below
-
Authors
You, Jianhua
Wu, Haidi
Tian, Jiaxin
Wen, Jianru
Shi, Wenbo
Wang, Zhi
Du, Yanjun
Xu, Hongwei
Wei, Hanyu
Li, Xiang
Kang, Wenyan
Zhou, Min
Gu, Zhidong
Qu, Jieming
-
Funding
Funding for this research was provided by:
AstraZeneca China (not applicable, not applicable, not applicable)
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 18 September 2024
First Online: 24 October 2024
Declarations
:
: The study was approved by the Ethics Committee of Ruijin-Hainan Hospital, Shanghai Jiao Tong University School of Medicine (approve no. KY2022-001). Written informed consent was obtained for the prospectively enrolled patients. The requirement for written informed consent was waived by the board for the retrospectively included patients.
: Not applicable.
: The authors declare no competing interests.
